Bagaan, Cherry S.
HRN: 26-24-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/20/2024
11/27/2024
IV
2 25gm
Q6H
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes